Industry Updates
This broad category includes articles concerning health insurance costs, carrier and health plan news, changing benefits technology, and surveys by the Kaiser Family Foundation and others on employee benefits.
The wide-ranging order requires the Department of Health and Human Services to seek public comment on the drug price negotiation program, which effectively requires manufacturers to agree to lower prices for certain drugs, for potential changes in upcoming years.
Starting in 5 days, the Department of Health and Human Services (HHS) may begin slashing regulations it considers to be unlawful or to exceed the agency’s authority, according to a memorandum sent by the president on Wednesday.
An investigation into the national security implications of pharma imports has been underway for two weeks, the Trump administration disclosed Monday.
California is projected to experience the largest potential losses in Medicaid coverage if federal work requirements are enacted.
Shares of U.S. health insurers jumped on Tuesday after a bigger-than-expected increase in the government’s reimbursement rates for Medicare Advantage plans in 2026 signaled some relief for a sector burdened with steep medical costs. Medicare-focused insurer Humana (HUM.N), opens new tab led gains with a 16% jump, while other health insurers including UnitedHealth Group (UNH.N), opens new tab, ...
President Donald Trump said Tuesday that pharmaceutical imports will soon be hit with “major” tariffs as part of his efforts to drive manufacturing back to the U.S. Drug imports evaded the first round of tariffs that Trump imposed on countries around the world, but the president said they will not be spared. “We’re going to ...
Health insurance premiums and related costs are a significant burden for small businesses, and a new study from banking giant JPMorgan Chase finds that many dropped coverage from one year to the next to mitigate the expense. The report, compiled by the JPMorgan Chase Institute, found that about a third of small businesses canceled their coverage between ...
Even before President Trump’s announcement that he plans a “major tariff” on pharmaceuticals, the sector was getting hammered in the markets — and not just over concerns about higher costs. Why it matters: Investors are also responding to broader uncertainty about the Food and Drug Administration and how the industry will be regulated, experts tell Axios. ...
The future of benefits selection should feel less like an overwhelming trip to an unfamiliar supermarket and more like the seamless, intuitive experience of online shopping.
A coalition of states sued the Trump administration last Tuesday over its decision to cut $11 billion in federal funds that go toward COVID-19 initiatives and various public health projects across the country.